An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect . Clinics [Internet]. 2011 Jan. 1 [cited 2024 Jun. 18];66(5):837-41. Available from: https://revistas.usp.br/clinics/article/view/19562